The abstract is read at the publisher; the summary is JClub's.
ASCO Living Guideline updates for advanced gastroesophageal cancer are continuously revised as new evidence emerges, with recommendations changing on a regular schedule.
- Why it matters: Rapidly evolving immunotherapy and targeted therapy evidence creates a need for frequent, systematic updates to keep clinical practice aligned with the latest findings.
- What they did: A standing expert panel systematically reviews the health literature on an ongoing basis and publishes regular guideline updates under ASCO’s living guideline methodology and conflict-of-interest policy.
- The result: The living guideline and its updates provide current recommendations for advanced gastroesophageal cancer while explicitly not replacing clinicians’ independent judgment for individual patients.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.